Gilead Sciences remdesivir
The Latest
-
WHO Recommends Against Use Of Remdesivir For Treating COVID-19
The World Health Organization said that there was insufficient evidence to recommend remdesivir for treating COVID-19 patients. 
The World Health Organization said that there was insufficient evidence to recommend remdesivir for treating COVID-19 patients. -
Gilead Sciences’ Remdesivir Is First FDA-Approved COVID-19 Treatment
One expert says the drug shows “modest" benefits but isn’t “a remarkable improvement." 
One expert says the drug shows “modest" benefits but isn’t “a remarkable improvement." -
Coronavirus: Latest COVID-19 Updates In South Korea
South Korea has been battling with multiple coronavirus clusters over the past few weeks but recently, imported cases have added to the government’s struggles. 
South Korea has been battling with multiple coronavirus clusters over the past few weeks but recently, imported cases have added to the government’s struggles. -
Coronavirus Update: Latest COVID-19 Treatment News
The world continues to wait for a potential COVID-19 treatment or vaccine that could propel countries to start getting back to life as usual. 
The world continues to wait for a potential COVID-19 treatment or vaccine that could propel countries to start getting back to life as usual. -
WHO Confirms Remdesivir Is A Promising Coronavirus Treatment
The WHO said on Monday that remdesivir is showing good signs of potentially treating coronavirus patients. 
The WHO said on Monday that remdesivir is showing good signs of potentially treating coronavirus patients.
